Different from autosomal-dominant DYT/PARK-GCH1 dystonia, the other forms are only partially responsive to L-Dopa and require additional treatment such as tetrahydrobiopterin, 5-hydroxytryptophan, or other dopaminergic medication (Opladen et al. 2020). The gene discussed is GCH1; the disease is late-onset Parkinson disease.